GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Censorship is a tool used by tyrants who want to mandate an agenda without discourse, due diligence, or opposition. Nowhere is this more clear than in the post COVID era, where science is commodified,...
The El Salvadoran-based MS-13 gang is a US-designated terrorist organization....
Democrats have indicated they will subpoena Trump if they win control of the House in the November election....
